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Background: An unusually high incidence of aseptic meningitis caused by enteroviruses was noted in Alberta,
Canada between March and October 2010. Sequence based typing was performed on the enterovirus positive
samples to gain a better understanding of the molecular characteristics of the Coxsackie A9 (CVA-9) strain
responsible for most cases in this outbreak.
Methods: Molecular typing was performed by amplification and sequencing of the VP2 region. The genomic
sequence of one of the 2010 outbreak isolates was compared to a CVA-9 isolate from 2003 and the prototype
sequence to study genetic drift and recombination.
Results: Of the 4323 samples tested, 213 were positive for enteroviruses (4.93%). The majority of the positives were
detected in CSF samples (n = 157, 73.71%) and 81.94% of the sequenced isolates were typed as CVA-9. The
sequenced CVA-9 positives were predominantly (94.16%) detected in patients ranging in age from 15 to 29 years
and the peak months for detection were between March and October. Full genome sequence comparisons
revealed that the CVA-9 viruses isolated in Alberta in 2003 and 2010 were highly homologous to the prototype
CVA-9 in the structural VP1, VP2 and VP3 regions but divergent in the VP4, non-structural and non-coding regions.
Conclusion: The increase in cases of aseptic meningitis was associated with enterovirus CVA-9. Sequence
divergence between the prototype strain of CVA-9 and the Alberta isolates suggests genetic drifting and/or
recombination events, however the sequence was conserved in the antigenic regions determined by the VP1, VP2
and VP3 genes. These results suggest that the increase in CVA-9 cases likely did not result from the emergence of a
radically different immune escape mutant.
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The enterovirus genome is comprised of a single open
reading frame flanked by the 5’ and 3’ untranslated regions
(UTRs), and the encoded polyprotein is cleaved to produce
the structural and nonstructural proteins [1]. Although
most infections are asymptomatic, non-polio enteroviruses
are the most common infectious cause of aseptic meningi-
tis [1]. Several outbreaks resulting from different entero-
virus serotypes have been described including but not* Correspondence: Raymond.Tellier@albertahealthservices.ca
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reproduction in any medium, provided the orrestricted to Coxsackievirus A9 (CVA-9) [2], EV71 [3,4],
EV68 [5], Coxsackievirus A24 [6], echovirus 18 [7], echo-
virus 30 [8,9], and Coxsackievirus A16 [10].
Non-polio enteroviruses were traditionally classified
into serotypes, based on a neutralization assay and in-
cluded 64 classical isolates consisting of Coxsackieviruses
A, Coxsackieviruses B, echoviruses and several numbered
enteroviruses [11]. Genetic studies led to a new classifica-
tion scheme, grouping the enteroviruses into species A, B,
C and D, although serotype determination is still widely
used, including for epidemiological purposes. Typing
methods based on sequencing have been previously de-
scribed in the VP1 [12-14], VP2 [15,16], and VP4 [17]
regions. Molecular typing methods based on the P1ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Distribution of the different serotypes detected in the
sequenced samples. A indicates serotype distribution in samples
from patients less than one year and B from patients over one
year old.
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equivalent results to neutralizing assays, which they have
essentially replaced [1,14]. Molecular typing has also led to
the characterization of new enterovirus serotypes [4,18-20]
and provides information on recombination between en-
teroviruses. This is a common phenomenon which almost
always occurs between viruses belonging to the same
species [1,21,22]. Serotype determination remains import-
ant for molecular epidemiology, in part because the capsid
contains the neutralization epitopes, and a rise or fall in in-
cidence of a serotype can be linked to serotype-specific
humoral immunity within the population [21]. The capsid
also determines the cellular receptors used by the virus
[23] and is thus an important determinant of viral patho-
genesis, although non-structural proteins also contribute
to the pathogenesis of the virus [24].
An unusually high incidence of aseptic meningitis was
noted in Alberta, Canada between March and October
2010 [25]. A high proportion of CSF samples submitted
to the Provincial Laboratory For Public Health of
Alberta were positive for enteroviruses and serotyping
by molecular methods revealed that majority of these
enteroviruses belonged to the CVA-9 serotype. The pri-
mary goal of this study was to provide a full genetic
characterization of the CVA-9 isolates responsible for
this outbreak. Secondary goals were to comment on the
methods of molecular serotyping for the diagnostic la-
boratory and on the use of long RT-PCR as a convenient
method to obtain the near full-length genomic sequence
of enteroviruses, especially when recombination events
are involved in the genesis of the viral genome. The gen-
ome sequence of these isolates was determined and
compared to the sequence of a CVA-9 isolate from
Alberta in 2003 and to the prototype CVA-9 sequence
(strain: Griggs; D00627) [26]. Serotyping by sequencing
within the VP2 region was found to be more reliable
than within the VP4 region. A comparison of the differ-
ent genes revealed a higher nucleotide and amino acid
conservation in the structural regions, and analysis of
the sequence of the non-structural region pointed to re-
combination events in the genesis of the 2010 isolate.
Results
Detection and serotyping
Of the 4323 samples tested, 213 were positive for en-
teroviruses (4.93%). The majority of the positives were
CSF samples (n = 157, 73.71%) followed by specimens of
respiratory origin (n = 17, 7.98%), stools (n = 10, 4.70%)
and plasma (n = 8, 3.76%). The rest of this analysis con-
centrates on CSF samples. A total of 72 positive CSF
samples were randomly selected to represent different
age groups, geographic locations and disease severity for
serotype determination based on phylogenetic clustering
of the partial sequence of the VP2 region with theprototype sequences. More than 85% of samples could
be typed without the need for culture or nested PCR
(data not shown). This RT-PCR detects both enterovi-
ruses and rhinoviruses, and allows for differentiation
based on the length of the amplicon.
The most common serotype detected was CVA-9 (n = 59,
81.94%) and it was clearly the predominant serotype in
the population. Closer examination of age distribution
revealed that the majority (n = 56, 94.92%) of the CVA-9
positives were from patients ranging in age from 15 to
29 years, only three (5.08%) CVA-9 positives were
detected in children less than a year old. The other fre-
quently detected serotypes were CVB-3 (n = 3) and
CVB-4 (n = 2). Figure 1A and 1B show the distribution
of the different serotypes detected from infants less than
one year old and from patients older than one year. A
phylogenetic tree including representatives of the differ-
ent enterovirus serotypes detected and some representa-
tive prototype strains in the VP2 region is indicated in
Figure 2. The VP2 sequence from all the sequenced
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Figure 2 Phylogenetic tree including representatives of the
different serotypes detected and corresponding prototype
sequences (in italics). The alignment used for the phylogenetic
tree included 173 bases of the VP2 region from the clinical
specimens, the same region from the prototype strains is also
included. The Genbank accession number for the prototype strains is
included in legend for Table 2. Patient samples are identified using a
laboratory number followed by the enterovirus type.
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ciated with a clonal or nearly clonal CVA-9 population.
Age and gender distribution
Of the 59 samples positive for CVA-9, roughly equal num-
bers were detected in males (n = 30) and females (n = 29).
Figure 3 shows the age distribution and percentage of CSF
samples positive for CVA-9 within the different age
groups tested. The data indicates that the majority of the
CVA-9 positives were detected in patients between 15 to
30 years old.
Seasonality
Samples from January 2010 to December 2010 were
used in this study; peak months for the detection of
CVA-9 positives in CSF samples were between March
and October.
Comparison of near full length genomes
The genomic sequences of the CVA-9_2003 and CVA-9
_2010 have been deposited in GenBank under accession
number JQ837913 and JQ837914, respectively. Compari-
son of the nucleotide and amino acid sequences in eachof the gene segments from CVA-9_2003 and CVA-9
_2010 to the prototype CVA-9 sequence are shown in
Table 1. Nucleotide identity in the 5’ untranslated region
(5’ UTR) between CVA-9_2003 and CVA-9_2010 was
higher (96.5%) than with the prototype CVA-9 sequence
which was around 85%. The nucleotide and amino acid
identity was high (around 95%) between CVA-9_2003
and CVA-9_2010 samples in the structural genes (VP4,
VP2, VP3 and VP1). The nucleotide identity in the struc-
tural genes for both these samples was lower (around
80%) when compared to the prototype CVA-9 sequence
but amino acid identity was high (around 90%) indicat-
ing that the nucleotide changes consisted mostly of syn-
onymous mutations. CVA-9_2010 showed some
sequence diversity from the CVA-9_2003 isolate in the
3’ non-structural domain. This domain encodes the 2A
protease, 2B protein, 2C helicase, 3A protein, 3B protein
(VPg), 3C protease and 3D protein (polymerase). The
nucleotide sequence identity in the 2A protease and 2B
protein regions was 96.15% and 93.60% respectively;
identity in the 2C helicase, 3A protein and 3D protein
was around 80%. The lowest nucleotide identity was ob-
served in the 3B protein at 74.63% and 3C protease at
77.78%, however amino acid conservation in these genes
was higher as indicated in Table 1. Comparison of these
gene segments to the prototype CVA-9 strain showed a
higher percent of amino acid identity as compared to
nucleotide identity.
Phylogenetic analysis comparing the nucleotide se-
quences of all the species B prototype sequences to
CVA-9_2003 and CVA-9_2010 shows that in the VP2 re-
gion, these sequences cluster with the prototype CVA-9
sequence with a high bootstrap value; a similar pattern
was observed for the VP1 and VP3 regions. However, in
the VP4 region, the closest neighbour to CVA-9_2003
and CVA-9_2010 sequences is enterovirus 101 (EV-101)
and there is significant divergence from the prototype
CVA-9 sequence at the nucleotide level (data not shown).
Table 2 lists the nearest neighbour based on phylogenetic
analysis for the structural and non-structural gene seg-
ments, compared to the gene sequences from prototype
strains. As indicated in the table the regions 2A, 2B, and
3B from the CVA-9_2003 and CVA-9_2010 cluster to-
gether, however, the 2C, 3A, 3C and 3D regions from
CVA-9_2003 and CVA-9_2010 cluster with different en-
terovirus species B prototype sequences indicating base
pair changes or recombination in these regions. The prob-
able mosaic nature of the genome of CVA-9_2003
and CVA-9_2010 was further explored by performing
Simplot analysis. Figure 4A compares the sequence of
CVA-9_2003 to that of the enteroviruses identified in
Table 2 as the most homologous in each gene. All the vi-
ruses are highly homologous within the 5’NC, and the
higher score of EV-74 may or may not reflect the origin of
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Figure 3 Age distribution of patients positive for enterovirus CVA-9. The bars represent the total number of samples positive for CVA-9 and
the broken line indicates the percentage of samples positive for CVA-9 among the serotyped samples in each age group. The solid line indicates
the percentage of samples positive for all enteroviruses in each age group based on the number of CSF samples tested within that age group.
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sequencing the 5’UTR would not allow for accurate sero-
typing. It shows that in the VP2-VP3-VP1 region the
CVA-9_2003 is most homologous to the prototype CVA-
9; it is speculated that the differences are attributable to
genetic drifting over the years. It is interesting to note that
in the VP4 region the highest homology is with EV-101,
suggesting that recombination with EV-101 (or a very
similar virus) might have occurred. This suggests that rely-
ing only on the VP4 sequence would not allow for accurate
serotyping. Simplot analysis also shows that in the non-
structural coding region, recombination with other viruses
of species B has occurred, although the dominance of indi-
vidual viruses is not clear enough to attribute the origin ofTable 1 Percent identity comparison of nucleotide and amino
(JQ837914) and prototype CVA-9 sequence (D00627)
2003 Vs 2010 200
Gene fragment Nucleotide Amino acid Nucleo
5’NCR 96.5 N/A 84.9
VP4 92.65 94.29 79.
VP2 94.76 94.03 80.9
VP3 95.24 97.51 81.3
VP1 94.92 95.47 82
2A Protease 96.15 97.31 77.7
2B Protein 93.6 83.33 79.4
2C Helicase 82.19 92.96 82.0
3A protein 81.34 93.48 73.0
3B Protein (VPg) 74.63 86.36 79.
3C Protease 77.78 91.62 81.7
3D Protein (Pol) 80.19 92.09 76.8the segments with certainty. Similarly, Figure 4B compares
the sequence of CVA-9_2010 to the enteroviruses identi-
fied in Table 2. Similar comments can be made regarding
the sequence of CVA-9_2010, although in the non-
structural domain, identifying CVB-6, EV-86 and EV-100
as contributing to the recombination events appears more
convincing. Tables 1 and 2 show that there is a high nu-
cleotide identity between CVA-9_2003 and CVA-9_2010
in the region upstream of that coding for protein 2B. It
can be speculated that CVA-9_2010 arose from recombin-
ation events between CVA-9_2003, CVB-6, EV-86 and
EV-100. This hypothesis is examined by Simplot analysis
in Figure 4C. This analysis suggests that CVA-9 (2010 and
2003) are highly homologous from the 5’NC to the 2Bacid sequences for isolates from 2003 (JQ837913), 2010
3 Vs Prototype CVA-9 2010 Vs Prototype CVA-9
tide Amino acid Nucleotide Amino acid
3 N/A 85.5 N/A
9 94.12 77.94 94.12
5 88.85 80.95 89.23
7 98.74 81.65 98.32
93.38 81.24 92.05
8 93.88 79.14 95.24
6 91.92 80.47 96.97
7 97.26 80.87 96.35
3 91.01 74.63 89.89
1 90.91 70.15 86.36
5 97.27 79.02 95.63
1 96.32 73.69 95.89
Table 2 Closest neighbour to the 2003 and 2010 samples
based on phylogenetic analysis
Gene
fragment
Closest neighbour
to 2003
Closest neighbour
to 2010
5’NCR EV74 EV74
VP4 EV101 EV101
VP2 CVA-9 CVA-9
VP3 CVA-9 CVA-9
VP1 CVA-9 CVA-9
2A Protease Echo 25 Echo 25
2B Protein CVB-5 and echo14 CVB-5 and echo14
2C Helicase Echo 25 CVB-6
3A protein Echo 16 and CVB-6 EV 86
3B Protein (VPg) Echo 14 and CVB-5 Echo 14 and CVB-5
3C Protease Echo 13 EV 100
3D Protein (Pol) Echo 13 EV 86
Phylogenetic analysis was performed using all the available prototype
sequences belonging to enterovirus species B.
Phylogenetic tree is based on complete nucleotide sequence of the VP2 and
VP4 genes; GenBank numbers for the prototype sequences used were
D00627_CVA-9; M16560_CVB1; AF085363_CVB2; M16572_CVB3; X05690_CVB4;
AF114383_CVB5; AF105342_CVB6; AF029859_E1; AY302545_E2; AY302553_E3;
AY302557_E4; AF083069_E5; AY302558_E6; AY302559_E7; X84981_E9;
X80059_E11; X79047_E12; AY302539_E13; AY302540_E14; AY302541_E15;
AY302542_E16; AY302543_E17; AF317694_E18; AY302544_E19; AY302546_E20;
AY302547_E21; AY302548_E24; AY302549_E25; AY302550_E26; AY302551_E27;
AY302552_E29; AF162711_E30; AY302554_E31; AY302555_E32; AY302556_E33;
AY302560_EV69; AF241359_EV73; AY556057_EV74; AY556070_EV75;
AJ493062_EV77; AY843297_EV79; AY843298_EV80; AY843299_EV81;
AY843300_EV82; AY843301_EV83; DQ902712_EV84; AY843303_EV85;
AY843304_EV86; AY843305_EV87; AY843306_EV88; AY843307_EV97;
NC_013115.1_EV107; DQ902713_EV100; AY843308_EV101. The GenBank
numbers for the in-house sequenced samples from 2003 and 2010 are
JQ837913 and JQ837914.
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beyond this point, with contributions from EV-86 and EV-
100, and likely from CVB-6.
Discussion
Recombination between enteroviruses is quite frequent,
and occurs typically within the same species [1,27]. It
was initially thought that the 5’UTR and P1 regions
move independently during recombination, and the fre-
quency of recombination was higher in the non-
structural coding region [22]. This lead to the conclusion
that serotyping by molecular methods involving sequen-
cing of the P1 region should be equivalent to sequencing
segments of this region (VP1,2,3 or 4). Several studies
have confirmed the finding that sequencing of the VP1
or VP2 regions yields similar typing results compared to
sequencing the entire P1 region [1,14,28]. Typing using
the VP4 region has yielded conflicting results including
studies reporting both consistent and inconsistent results
with classical serotyping [28,29]; Perera et al. have noted
that the VP4 sequence is unreliable for serotyping of
viruses in species B and C [29]. This inconsistency seemsto result from recombination events involving the VP4 re-
gion [22]. Intuitively, one may still continue to regard the
segment coding for the external domains of the capsid to
recombine as a block since the VP4 domain remains com-
pletely inside the capsid and is inaccessible to antibodies
[1].
The amplicon used for serotype determination in-
cludes a segment from the 5’UTR, the VP4 region and a
segment of the VP2 region; but given the possibility of
recombinations outside the VP2-VP3-VP1 region, only
the sequence within VP2 was used for the typing of sam-
ples in this study. It was noted that if serotype assign-
ment is made based on Blast comparisons with the
GenBank database sequences, there is a potential for in-
accurate serotype assignment since contemporary iso-
lates submitted into GenBank may have been serotyped
based on the VP4 sequence, which can reassort inde-
pendently of the VP2-VP3-VP1 segment. In this study,
the serotype assignment was achieved by constructing a
phylogenetic tree with the partial VP2 sequence obtained
by sequencing the amplicon and the corresponding VP2
sequences of the original prototype strains [1]. In spite
of the genetic drift evident in the sequences of contem-
porary viruses, this method provided unambiguous sero-
type assignment. Instances of recombination within the
VP2-VP3-VP1 segment have only been rarely reported.
Al-Hello and colleagues reported on an isolate that was
identified as echovirus 11 by genetic analysis, but could
be neutralized by antisera specific for echovirus 11 or
CVA-9. A peptide scan analysis confirmed the presence
of epitopes recognized by both antisera, whereas a
Simplot analysis failed to reveal a recombination event
within the capsid [30]. Should reports of isolates with
similar properties become more frequent, the very con-
cept of enterovirus serotype might become untenable.
Notwithstanding these considerations, at this point in
time it remains valuable to serotype isolates, because the
serotype is determined by the neutralizing epitopes, and
remains important for the molecular epidemiology of
these viruses. In addition, the capsid determines the
choice of the cellular receptor, consequently the serotype
is an important factor to determine the pathogenicity of
an isolate [23]; however, the remainder of the genome
also contributes to pathogenicity [24] and complete gen-
ome sequencing is required for full characterisation of
an isolate.
During the 2010 outbreak, a different serotype distri-
bution was noted among infants (< 1year) and older in-
dividuals, this difference in distribution of serotypes
between age groups has been noted before [31,32]. The
serotypes found among infants included in our study
have been typically associated with neonatal disease, for
example, Coxsackie B3 and B4, echovirus 9, and EV-71.
It was interesting to observe one isolate with the VP2
VP
45’UTR VP2-VP3-VP1 2A-2B-2C-3A-3B-3C-3D 3’UTR
VP
45’UTR VP2-VP3-VP1 2A-2B-2C-3A-3B-3C-3D 3’UTR
VP
45’UTR VP2-VP3-VP1 2A-2B-2C-3A-3B-3C-3D 3’UTR
A
B
C
Figure 4 Simplot analysis of full genome sequences of CVA-9_2003, CVA-9_2010 and related species B sequences. Genomic regions are
indicated at the bottom of each panel based on numbering of the prototype CVA-9 (D00627) 5’UTR:1–722; VP4:723–929; VP2:930–1712;
VP3:1713–2426; VP1:2427–3332; 2A:3333–3773; 2B:3774–4069; 2C:4070–5057; 3A:5058–5323; 3B:5324–5390; 3C:5391–5938; 3D:5939–7324;
3’UTR:7325 - >7403. The query sequences used are CVA-9_2003 in panel 4A and CVA-9_2010 in panels 4B and 4C. Arrows in panels 4A and 4B
indicate recombination with EV-101 in the VP4 region.
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Among the rest of the population, CVA-9 was clearly the
predominant serotype. Phylogenetic analysis of the VP2 re-
gion from the CVA-9 isolates showed that all the isolates
had the same sequences and therefore originated from the
same strain.
Comparison of the capsid regions showed the
CVA-9_2003 and CVA-9_2010 isolates to be highlyhomologous and this was corroborated by Simplot
anaysis; consequently it is speculated that the sudden in-
crease in detection of CVA-9 in CSF samples is attribut-
able to an increased number of individuals susceptible
to CVA-9 in the population rather than to the emer-
gence of an immune escape mutant in 2010. For an in-
fectious agent to cause an outbreak, it is necessary that
the herd immunity of the population drops below a
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number R0 [33]. For CVA-9 to re-enter the population
of Alberta in 2010, either the new isolate was an im-
mune escape mutant against which the population had
no prior immunity, or the herd immunity had declined
below the threshold. Because of the very high homology
in the capsid sequences between the 2003 and 2010 iso-
lates, it does not seem likely that the 2010 isolate was an
immune escape mutant.
A comparison with the sequence of the prototype
CVA-9 shows that the two Alberta isolates inherited
their VP2-VP3-VP1 segment from the prototype, but the
VP4 segment shows sequence divergence. For all the
other protein coding segments, phylogenetic trees of the
nucleotide sequence were constructed to compare the
Alberta strains with the prototype strains within species
B, and Simplot analysis were performed. Two important
observations can be made: firstly, the two Alberta iso-
lates are highly homologous in most regions, with few
changes that can be largely attributed to sequence drift;
however, recombination has likely occurred in the 2C,
3A, 3C, and 3D regions. Secondly, the Alberta isolates are
very different from the prototype CVA-9 in the VP4
segment (supporting the concept that VP4 can be a site for
recombination). The 5’NC, structural and non-structural
regions appear to be components of a mosaic genome
modified from the prototype CVA-9 by recombination and
drifting. Similar observations have been made on other
contemporary CVA-9 strains [34], and indeed in other
contemporary enteroviruses within species B [22,27]. How
much the pathogenicity of these CVA-9 viruses has been
modified by the non-structural genes, compared to the
prototype strain, is unclear [22].
Conclusion
In summary the sudden increase in cases of aseptic
meningitis in Alberta in 2010 was associated with en-
terovirus CVA-9. The capsid region was highly homolo-
gous to the capsid of a 2003 isolate, suggesting that the
infections were not the result of the emergence of an
immune escape mutant. We thus speculate that the in-
crease in the number of infections may have resulted
from a decline in the level of herd immunity against this
virus to a level where the virus was able to penetrate the
population. When compared to the prototype strain of
CVA-9, the Alberta isolates displayed signs of multiple
recombination events in addition to genetic drifting.
Methods
Screening for enteroviruses
Specimens submitted to the Provincial Laboratory for
Public Health (ProvLab) for enterovirus testing from
January 1 to December 31, 2010 were included in this
study. A total of 4323 samples from patients ranging in agefrom one day old to 97 years of age were tested; the most
common specimen types tested included CSF (n = 2687,
62.16%), plasma (n = 497, 11.50%), nasopharyngeal and
throat swabs (n = 213, 4.93%) and stools (n = 103,
2.40%). Viral RNA was extracted using the easyMAGW
automated extractor (BioMérieux, Durham, NC, USA)
and the extracted nucleic acid was screened for entero-
viruses using a previously published NASBA assay [35].
Serotyping of enteroviruses
Enteroviruses were serotyped using one-step RT-PCR to
amplify the partial 5’untranslated region (293 bp), the
VP4 region (207 bp) and partial VP2 region (250 bp) using
previously described primers 1-EV/RV and 2-EV/RV from
RNA extracted directly from the specimen [36]. Sequen-
cing was performed without the need for nested amplifica-
tion. Amplification was performed using the One-step
RT-PCR kit from Qiagen (Ontario, Canada) using 10 μl of
5X buffer, 10 μl of Q solution, 2 μl of 10 mM dNTPs, 2 μl
of enzyme, 0.125 μl of RNaseOUT (Life Technologies,
Ontario, Canada), 0.8 μM of primers and 5 μl of template
nucleic acid in a total volume of 50 μl. The reverse
transcription step was performed at 50°C for 30 mins,
followed by enzyme activation at 95°C for 15 mins. The
amplification protocol included 45 cycles of denaturation
at 95°C for 30 seconds, followed by annealing at 55°C for
1.5 minutes and amplification at 72°C for 60 seconds. A
final extension step was performed for 10 minutes at 72°C
followed by cooling. Amplified products were sequenced
in both directions on the ABI PRISM 3130-Avant Genetic
Analyzer (Applied Biosystems (ABI), Foster City, CA).
Complete genome sequencing of CVA-9
Two enterovirus positive samples from 2003 (CVA-9_2003)
and 2010 (CVA-9_2010) with a high viral load as estimated
by the Ct value, that exhibited strong growth in primary
Rhesus Monkey Kidney cells from Diagnostic Hybrids
(Ohio, USA) were used. The near-complete genome of
these viruses was amplified by long RT-PCR as previ-
ously described [37]. The amplicons were sequenced by
genome walking and contig assembly was performed
using seqscape v2.5 (ABI). The genomic sequences of
the CVA-9_2003 and CVA-9_2010 have been deposited
in GenBank under accession numbers JQ837913 and
JQ837914, respectively.
Sequence analysis
Sequences were aligned using ClustalX (Version 1.81,
March 2000; ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalX/)
and phylogenetic analysis was conducted using Treecon
[38]. Distance estimation was performed using the Jukes
and Cantor distance correction (1969), topology inference
was performed using the neighbour joining method, and
bootstraping was done using 1000 replicates and the tree
Pabbaraju et al. Virology Journal 2013, 10:93 Page 8 of 9
http://www.virologyj.com/content/10/1/93was re-rooted at the internode. Simplot analysis were
performed using alignments done with CLustalX and the
Simplot for Windows v3.5.1 program [39].
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